lncRNAs are involved in tumor cell lipid metabolism by targeting different signaling pathways
lncRNAs are involved in tumor cell lipid metabolism by targeting different signaling pathways. Colorectal cancer: SNHG16 targets the Wnt signaling pathway to promote lipid synthesis and tumor growth. Liver cancer: HULC downregulates the expression of tumor suppressor p18 and promotes tumor cell growth. The aberrant lipid metabolism regulated by HULC promotes cancer cell proliferation and rapid tumor growth, a process that requires the involvement of ACSL1 and cholesterol throughout. Cholesterol synthesized from acetyl CoA upregulates HULC expression through the activation of RXRA, and high HULC expression downregulates miR-9 expression, which in turn upregulates the expression of the transcription factor PPARα in hepatocellular carcinoma cells to activate ACSL1, thereby significantly upregulating ACSL1 and promoting tumor growth. Acetyl-CoA also synthesizes FAs and palmitic acid is an FA that produces diglycerides, which may be interconverted with triglycerides. NEAT1 activates the PPARα signaling pathway directly through ATGL or indirectly through free fatty acids and DAG, thereby increasing FA oxidation and thus, the tumor keeps growing. Prostatic cancer: Low expression of PCA3 upregulates miR-132-3P expression, while high expression of miR-132-3P inhibits SREBP-1 expression, thereby suppressing TG and cholesterol levels in prostate cancer cells and slowing down the tumor cell growth. Intrahepatic cholangiocarcinoma: Knockout of HAGLROS inhibits intrahepatic cholangiocarcinoma proliferation and growth, inactivates the mTOR axis and promotes autophagy. ACSL1, long-chain acyl CoA synthetase 1; ATGL, adipose tissue triglyceride lipase; CHOL, cholesterol; DAG, diacylglycerol; HAGLROS, HAGLR opposite strand long non-coding RNA; HULC, highly upregulated in liver cancer; miR, microRNA; mTOR, mammalian target of rapamycin; NEAT1, nuclear paraspeckle assembly transcript 1; PA, palmitic acid; PCA3, prostate cancer antigen 3; PPARα, peroxisomal proliferator-activated receptor α; RXRA, RXR-α; SNHG16, small nucleolar RNA host gene 16; SREBP-1, sterol regulatory element-binding protein 1; TG, triglyceride; FA, fatty acid
Publication
Long non‑coding RNAs, lipid metabolism and cancer (Review) (2023) Zhen-Dong Zhang, et al. Exp Ther Med. 2023 Oct;26(4). Figure: F1.| Organism | Group | Word | Match | Source | NCBI Symbol | NCBI ID |
|---|---|---|---|---|---|---|
| Homo sapiens | Primates | Wnt | WNT | famplex_relations | WNT1 | 7471 |
| Homo sapiens | Primates | Wnt | WNT | famplex_relations | WNT2 | 7472 |
| Homo sapiens | Primates | Wnt | WNT | famplex_relations | WNT2B | 7482 |
| Homo sapiens | Primates | Wnt | WNT | famplex_relations | WNT3 | 7473 |
| Homo sapiens | Primates | Wnt | WNT | famplex_relations | WNT3A | 89780 |
| Homo sapiens | Primates | Wnt | WNT | famplex_relations | WNT4 | 54361 |
| Homo sapiens | Primates | Wnt | WNT | famplex_relations | WNT6 | 7475 |
| Homo sapiens | Primates | Wnt | WNT | famplex_relations | WNT7A | 7476 |
| Homo sapiens | Primates | Wnt | WNT | famplex_relations | WNT7B | 7477 |
| Homo sapiens | Primates | Wnt | WNT | famplex_relations | WNT8A | 7478 |
| Homo sapiens | Primates | Wnt | WNT | famplex_relations | WNT8B | 7479 |
| Homo sapiens | Primates | Wnt | WNT | famplex_relations | WNT9A | 7483 |
| Homo sapiens | Primates | Wnt | WNT | famplex_relations | WNT9B | 7484 |
| Homo sapiens | Primates | Wnt | WNT | famplex_relations | WNT10A | 80326 |
| Homo sapiens | Primates | Wnt | WNT | famplex_relations | WNT10B | 7480 |
| Homo sapiens | Primates | Wnt | WNT | famplex_relations | WNT11 | 7481 |
| Homo sapiens | Primates | Wnt | WNT | famplex_relations | WNT16 | 51384 |
| Homo sapiens | Primates | Wnt | WNT | famplex_relations | WNT5A | 7474 |
| Homo sapiens | Primates | Wnt | WNT | famplex_relations | WNT5B | 81029 |
| Homo sapiens | Primates | RXRA | RXRA | ncbigene_symbol | RXRA | 6256 |
| Homo sapiens | Primates | TG | TG | ncbigene_symbol | TG | 7038 |
| Homo sapiens | Primates | PPARα | PPAR | ncbigene_synonym | PPARA | 5465 |
| Homo sapiens | Primates | PPARα | PPAR | famplex_relations | PPARD | 5467 |
| Homo sapiens | Primates | PPARα | PPAR | famplex_relations | PPARG | 5468 |
| Homo sapiens | Primates | SNHG16 | SNHG16 | ncbigene_symbol | SNHG16 | 100507246 |
| Homo sapiens | Primates | P18 | P18 | ncbigene_synonym | CDKN2C | 1031 |
| Homo sapiens | Primates | P18 | P18 | ncbigene_synonym | UBE2I | 7329 |
| Homo sapiens | Primates | P18 | P18 | ncbigene_synonym | MAFK | 7975 |
| Homo sapiens | Primates | P18 | P18 | ncbigene_synonym | EEF1E1 | 9521 |
| Homo sapiens | Primates | P18 | P18 | ncbigene_synonym | ZNF197 | 10168 |
| Homo sapiens | Primates | P18 | P18 | ncbigene_synonym | ATRAID | 51374 |
| Homo sapiens | Primates | P18 | P18 | ncbigene_synonym | LAMTOR1 | 55004 |
| Homo sapiens | Primates | P18 | P18 | ncbigene_synonym | TPPP2 | 122664 |
| Homo sapiens | Primates | P18 | P18 | ncbigene_synonym | H3P12 | 100689229 |
| Homo sapiens | Primates | HULC | HULC | ncbigene_symbol | HULC | 728655 |
| Homo sapiens | Primates | ATGL | ATGL | ncbigene_synonym | PNPLA2 | 57104 |
| Homo sapiens | Primates | ACSL1 | ACSL1 | ncbigene_symbol | ACSL1 | 2180 |
| Homo sapiens | Primates | PCA3 | PCA3 | ncbigene_symbol | PCA3 | 50652 |
| Homo sapiens | Primates | HAGLROS | HAGLROS | ncbigene_symbol | HAGLROS | 102800310 |
| Homo sapiens | Primates | SREBP1 | SREBP1 | ncbigene_synonym | SREBF1 | 6720 |
| Homo sapiens | Primates | mTOR | MTOR | ncbigene_symbol | MTOR | 2475 |
| Word | Match | MeSH | Name | ChEBI |
|---|---|---|---|---|
| Fatty acids | fatty acids | fatty acids | chebi:35366 |
Disease mentions
| Word | Match | MeSH | Name | DOID |
|---|---|---|---|---|
| cancer | cancer | cancer | DOID:162 | |
| cancer | cancer | cancer | DOID:162 | |
| cancer | cancer | cancer | DOID:162 | |
| cholangiocarcinoma | cholangiocarcinoma | cholangiocarcinoma | DOID:4947 | |
| Colorectal cancer | colorectal cancer | colorectal cancer | DOID:9256 | |
| Liver cancer | liver cancer | liver cancer | DOID:3571 | |
| Intrahepatic cholangiocarcinoma | intrahepatic cholangiocarcinoma | intrahepatic cholangiocarcinoma | DOID:4928 |